• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

创伤急性期纤维蛋白原的动态变化

Dynamics of fibrinogen in acute phases of trauma.

作者信息

Hayakawa Mineji

机构信息

Emergency and Critical Care Center, Hokkaido University Hospital, N14W5 Kita-ku, Sapporo, 060-8648, Japan.

出版信息

J Intensive Care. 2017 Jan 20;5(1):3. doi: 10.1186/s40560-016-0199-3.

DOI:10.1186/s40560-016-0199-3
PMID:34798699
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8600928/
Abstract

Fibrinogen is a unique precursor of fibrin and cannot be compensated for by other coagulation factors. If plasma fibrinogen concentrations are insufficient, hemostatic clots cannot be formed with the appropriate firmness. In severe trauma patients, plasma fibrinogen concentrations decrease earlier and more frequently than other coagulation factors, predicting massive bleeding and death. We review the mechanisms of plasma fibrinogen concentration decrease, which include coagulation activation-induced consumption, hyper-fibrino(geno)lysis-induced degradation, and dilution by infusion/transfusion. Understanding the mechanisms of plasma fibrinogen concentration decrease in severe trauma patients is crucial.

摘要

纤维蛋白原是纤维蛋白的独特前体,不能被其他凝血因子代偿。如果血浆纤维蛋白原浓度不足,就无法形成具有适当强度的止血凝块。在严重创伤患者中,血浆纤维蛋白原浓度比其他凝血因子更早、更频繁地降低,这预示着大出血和死亡。我们综述了血浆纤维蛋白原浓度降低的机制,包括凝血激活诱导的消耗、高纤维蛋白(原)溶解诱导的降解以及输注/输血引起的稀释。了解严重创伤患者血浆纤维蛋白原浓度降低的机制至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f346/8600928/9449af590998/40560_2016_199_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f346/8600928/7cefb589f931/40560_2016_199_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f346/8600928/9449af590998/40560_2016_199_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f346/8600928/7cefb589f931/40560_2016_199_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f346/8600928/9449af590998/40560_2016_199_Fig2_HTML.jpg

相似文献

1
Dynamics of fibrinogen in acute phases of trauma.创伤急性期纤维蛋白原的动态变化
J Intensive Care. 2017 Jan 20;5(1):3. doi: 10.1186/s40560-016-0199-3.
2
Pathophysiology of trauma-induced coagulopathy: disseminated intravascular coagulation with the fibrinolytic phenotype.创伤性凝血病的病理生理学:具有纤维蛋白溶解表型的弥散性血管内凝血。
J Intensive Care. 2017 Jan 31;5:14. doi: 10.1186/s40560-016-0200-1. eCollection 2017.
3
Disseminated intravascular coagulation at an early phase of trauma is associated with consumption coagulopathy and excessive fibrinolysis both by plasmin and neutrophil elastase.创伤早期弥散性血管内凝血与消耗性凝血病和纤溶亢进有关,纤溶亢进由纤溶酶和中性粒细胞弹性蛋白酶共同引起。
Surgery. 2011 Feb;149(2):221-30. doi: 10.1016/j.surg.2010.06.010. Epub 2010 Jul 23.
4
Fibrinogen depletion after plasma-dilution: impairment of proteolytic resistance and reversal via clotting factor concentrates.血浆稀释后纤维蛋白原耗竭:抗蛋白水解能力受损及通过凝血因子浓缩物逆转。
Thromb Haemost. 2014 Mar 3;111(3):417-28. doi: 10.1160/TH13-06-0497. Epub 2013 Nov 7.
5
Disseminated intravascular coagulation or acute coagulopathy of trauma shock early after trauma? An observational study.创伤后早期弥散性血管内凝血或创伤性休克急性凝血病?一项观察性研究。
Crit Care. 2011;15(6):R272. doi: 10.1186/cc10553. Epub 2011 Nov 17.
6
Relative effects of plasma, fibrinogen concentrate, and factor XIII on ROTEM coagulation profiles in an in vitro model of massive transfusion in trauma.在创伤大量输血体外模型中,血浆、纤维蛋白原浓缩物和凝血因子 XIII 对旋转血栓弹力图凝血曲线的相对影响。
Scand J Clin Lab Invest. 2017 Oct;77(6):397-405. doi: 10.1080/00365513.2017.1334128. Epub 2017 Jun 20.
7
Description of compensated and uncompensated disseminated intravascular coagulation (DIC) responses (non-overt and overt DIC) in baboon models of intravenous and intraperitoneal Escherichia coli sepsis and in the human model of endotoxemia: toward a better definition of DIC.狒狒静脉内和腹腔内大肠杆菌败血症模型以及人类内毒素血症模型中代偿性和失代偿性弥散性血管内凝血(DIC)反应(非显性和显性DIC)的描述:旨在更好地定义DIC
Crit Care Med. 2000 Sep;28(9 Suppl):S12-9. doi: 10.1097/00003246-200009001-00004.
8
High fibrin/fibrinogen degradation product to fibrinogen ratio is associated with 28-day mortality and massive transfusion in severe trauma.高纤维蛋白/纤维蛋白原降解产物与纤维蛋白原比值与严重创伤患者的28天死亡率及大量输血相关。
Eur J Trauma Emerg Surg. 2018 Apr;44(2):291-298. doi: 10.1007/s00068-017-0844-0. Epub 2017 Sep 18.
9
Fibrinogen level deteriorates before other routine coagulation parameters and massive transfusion in the early phase of severe trauma: a retrospective observational study.纤维蛋白原水平在严重创伤早期的其他常规凝血参数和大量输血之前恶化:一项回顾性观察研究。
Semin Thromb Hemost. 2015 Feb;41(1):35-42. doi: 10.1055/s-0034-1398379. Epub 2015 Jan 15.
10
Massive transfusion and coagulopathy: pathophysiology and implications for clinical management.大量输血与凝血病:病理生理学及对临床管理的意义
Can J Anaesth. 2006 Jun;53(6 Suppl):S40-58. doi: 10.1007/BF03022251.

引用本文的文献

1
Biomarkers in Venous Thrombosis: Diagnostic Potential and Limitations.静脉血栓形成中的生物标志物:诊断潜力与局限性
Biology (Basel). 2025 Jul 1;14(7):800. doi: 10.3390/biology14070800.
2
Fibrinogen levels and bleeding risk in adult extracorporeal cardiopulmonary resuscitation: multicenter observational study subanalysis.成人体外心肺复苏中纤维蛋白原水平与出血风险:多中心观察性研究亚分析
Res Pract Thromb Haemost. 2025 Feb 7;9(2):102700. doi: 10.1016/j.rpth.2025.102700. eCollection 2025 Feb.
3
Predictive haemostatic biomarkers and transfusion efficacy, insights from fresh frozen plasma use in surgical patients, preliminary results.

本文引用的文献

1
Pilot Randomized trial of Fibrinogen in Trauma Haemorrhage (PRooF-iTH): study protocol for a randomized controlled trial.纤维蛋白原用于创伤性出血的初步随机试验(PRooF-iTH):一项随机对照试验的研究方案
Trials. 2016 Jul 19;17(1):327. doi: 10.1186/s13063-016-1439-5.
2
Early coagulation events induce acute lung injury in a rat model of blunt traumatic brain injury.早期凝血事件在钝性创伤性脑损伤大鼠模型中诱发急性肺损伤。
Am J Physiol Lung Cell Mol Physiol. 2016 Jul 1;311(1):L74-86. doi: 10.1152/ajplung.00429.2015. Epub 2016 May 17.
3
HIGH D-DIMER LEVELS PREDICT A POOR OUTCOME IN PATIENTS WITH SEVERE TRAUMA, EVEN WITH HIGH FIBRINOGEN LEVELS ON ARRIVAL: A MULTICENTER RETROSPECTIVE STUDY.
预测性止血生物标志物与输血疗效:手术患者使用新鲜冰冻血浆的新见解,初步结果。
BMC Res Notes. 2024 Nov 9;17(1):332. doi: 10.1186/s13104-024-06992-5.
4
Suppressing upregulation of fibrinogen after polytrauma mitigates thrombosis in mice.抑制多发伤后纤维蛋白原的上调可减轻小鼠血栓形成。
J Trauma Acute Care Surg. 2024 Sep 6. doi: 10.1097/TA.0000000000004442.
5
Revolutionizing trauma care: advancing coagulation management and damage control anesthesia.革新创伤护理:推进凝血管理与损伤控制麻醉。
Anesth Pain Med (Seoul). 2024 Apr;19(2):73-84. doi: 10.17085/apm.24038. Epub 2024 Apr 30.
6
Biomechanics, Energetics, and Structural Basis of Rupture of Fibrin Networks.纤维蛋白网络破裂的生物力学、能量学和结构基础。
Adv Healthc Mater. 2023 Oct;12(27):e2300096. doi: 10.1002/adhm.202300096. Epub 2023 Aug 31.
7
Experimental Models of Traumatic Injuries: Do They Capture the Coagulopathy and Underlying Endotheliopathy Induced by Human Trauma?创伤性损伤的实验模型:它们能否捕捉到人类创伤引起的凝血功能障碍和潜在的内皮病变?
Int J Mol Sci. 2023 Jul 6;24(13):11174. doi: 10.3390/ijms241311174.
8
Engineering a Two-Component Hemostat for the Treatment of Internal Bleeding through Wound-Targeted Crosslinking.通过创伤靶向交联工程化的双组份止血剂治疗内出血。
Adv Healthc Mater. 2023 Aug;12(20):e2202756. doi: 10.1002/adhm.202202756. Epub 2023 Apr 23.
9
Emergency administration of fibrinogen concentrate for haemorrhage: systematic review and meta-analysis.紧急给予纤维蛋白原浓缩物治疗出血:系统评价和荟萃分析。
World J Emerg Surg. 2023 Mar 30;18(1):27. doi: 10.1186/s13017-023-00497-5.
10
Perioperative Considerations in Management of the Severely Bleeding Coagulopathic Patient.严重出血性凝血功能障碍患者的围手术期处理注意事项。
Anesthesiology. 2023 May 1;138(5):535-560. doi: 10.1097/ALN.0000000000004520.
高D-二聚体水平预示着严重创伤患者的不良预后,即便入院时纤维蛋白原水平较高:一项多中心回顾性研究。
Shock. 2016 Mar;45(3):308-14. doi: 10.1097/SHK.0000000000000542.
4
Pathophysiology of Trauma-Induced Coagulopathy and Management of Critical Bleeding Requiring Massive Transfusion.创伤性凝血病的病理生理学及大量输血所致严重出血的管理
Semin Thromb Hemost. 2016 Mar;42(2):155-65. doi: 10.1055/s-0035-1564831. Epub 2015 Dec 30.
5
Thrombin generation and procoagulant microparticle profiles after acute trauma: A prospective cohort study.急性创伤后凝血酶生成及促凝微粒谱:一项前瞻性队列研究。
J Trauma Acute Care Surg. 2015 Nov;79(5):726-31. doi: 10.1097/TA.0000000000000839.
6
Injectable hemostatic adjuncts in trauma: Fibrinogen and the FIinTIC study.创伤中的可注射止血辅助剂:纤维蛋白原与FIinTIC研究。
J Trauma Acute Care Surg. 2015 Jun;78(6 Suppl 1):S76-82. doi: 10.1097/TA.0000000000000632.
7
Local hemostasis, immunothrombosis, and systemic disseminated intravascular coagulation in trauma and traumatic shock.创伤及创伤性休克中的局部止血、免疫血栓形成和全身弥散性血管内凝血
Crit Care. 2015 Feb 23;19(1):72. doi: 10.1186/s13054-015-0735-x.
8
Rapid evaluation of fibrinogen levels using the CG02N whole blood coagulation analyzer.使用 CG02N 全血凝血分析仪快速评估纤维蛋白原水平。
Semin Thromb Hemost. 2015 Apr;41(3):267-71. doi: 10.1055/s-0035-1547372. Epub 2015 Apr 3.
9
Endogenous plasminogen activators mediate progressive intracerebral hemorrhage after traumatic brain injury in mice.内源性纤溶酶原激活剂介导小鼠创伤性脑损伤后的进行性脑出血。
Blood. 2015 Apr 16;125(16):2558-67. doi: 10.1182/blood-2014-08-588442. Epub 2015 Feb 11.
10
Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial.严重创伤患者血浆、血小板和红细胞以1:1:1与1:1:2比例输注及死亡率:PROPPR随机临床试验
JAMA. 2015 Feb 3;313(5):471-82. doi: 10.1001/jama.2015.12.